Make Genomic
Evidence Actionable
Simplify complex genetic data into actionable insights for patient diagnosis and precision medicine development with Genomenon's software, data, and services.
ACMG Secondary Findings
Now in Mastermind
Genonemon Targets WGS Analysis Costs with Curated ACMG Secondary Findings
The World's Most Comprehensive
Source of Genomic Evidence
The Mastermind Genomic Intelligence Platform
On Demand
Curation Experts
Genomenon now offers evidence curation and variant classification services, accessed on-demand, or as a longer-term extension of your own team.
Never Miss a
Diagnosis
Accelerate variant interpretation and increase your diagnostic yield with rapid search and comprehensive genomic insights.
Inform Your Drug Program
Partner with us to gain rapid, evidence-based insights that de-risk your program from discovery to commercialization.
What We Offer
Software
Explore our platforms for germline and somatic variant interpretation
Access article information on more than 26 million variants, as well as curated germline variant content.
Our Cancer Knowledgebase is used to interpret cancer variants, connecting them to therapies and clinical trials.
.png)
Services
Our expert team provides tailored consulting services to support your genomic projects. From custom variant analysis to clinical trial support and regulatory guidance, we ensure you have the expert insights needed for your specific genomic challenges.
Data
Gain access to an expansive, constantly updated database of curated genomic information. This resource offers a wealth of gene-disease associations and variant data, whether indexed or curated, delivered via an API or flat files for direct integration into your tertiary analytic platform.
The Race to Curate
the Human Genome
Our goal is to unlock the full potential of genomic data, transforming it into actionable knowledge that can revolutionize healthcare and research.
Helping to Make an Impact
Unraveling Genomic Complexity: Expert Insights Variant Curation Interpretation
Developing Treatments for Rare Disease
The End of VUS? Impact on Diagnosis and Treatment of Rare Diseases
Medium length heading goes here
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Trusted by Industry Leaders Including
Find out how we can help your organization
